Clinical and real-world evidence have demonstrated the potential of GLP-1RAs to reduce the risk of all-cause dementia and dementia due to AD in people with T2D [32, 34,35,36], and liraglutide has been shown to reduce neurodegeneration and the speed of decline in cognitive function in people with AD [29, 30]
I do agree with you on forecasting elements, but typically the results arent as drastic because they dont require as many human lifestyle changes
For many in the military, Wegovy is the more likely approved path for weight loss rather than Ozempic
They're marketed as being cheaper, easier to use, and available to anyone, unlike prescription weight loss injections, which require a consultation and have specific eligibility criteria